MYC Can Induce DNA Breaks In vivo and In vitro Independent of Reactive Oxygen Species
MYC overexpression is thought to initiate tumorigenesis by inducing cellular proliferation
and growth and to be restrained from causing tumorigenesis by inducing cell cycle arrest, …
and growth and to be restrained from causing tumorigenesis by inducing cell cycle arrest, …
Convalescent plasma (hyperimmune immunoglobulin) for COVID-19 management: An update
…, S Dolia, N Shah, S Verma, S Savale, S Ray - Process …, 2023 - Elsevier
The pandemic COVID-19 has spread widely throughout the globe and has been responsible
for millions of deaths worldwide. Recently, it has been identified that there is no specific …
for millions of deaths worldwide. Recently, it has been identified that there is no specific …
[HTML][HTML] HCV core/gC1qR interaction arrests T cell cycle progression through stabilization of the cell cycle inhibitor p27Kip1
ZQ Yao, A Eisen-Vandervelde, S Ray, YS Hahn - Virology, 2003 - Elsevier
Hepatitis C virus (HCV) is efficient in the establishment of persistent infection. We have
previously shown that HCV core protein inhibits T cell proliferation through its interaction with the …
previously shown that HCV core protein inhibits T cell proliferation through its interaction with the …
Hepatitis C virus: immunosuppression by complement regulatory pathway
ZQ Yao, S Ray, A Eisen-Vandervelde… - Viral …, 2001 - liebertpub.com
Hepatitis C virus (HCV) infection in humans is almost invariably associated with viral
persistence and chronic hepatitis. HCV-induced chronic hepatitis is a major risk factor for the …
persistence and chronic hepatitis. HCV-induced chronic hepatitis is a major risk factor for the …
Safety and efficacy of COVID-19 hyperimmune globulin (HIG) solution in the treatment of active COVID-19 infection-Findings from a Prospective, Randomized …
…, A Chaturvedi, N Shah, P Patel, R Patel, S Ray - medRxiv, 2021 - medrxiv.org
Background COVID-19 hyper-immune globulin (HIG) solution is a human plasma-derived,
highly-purified, concentrated, virus-inactivated preparation of neutralizing antibodies (NAbs) …
highly-purified, concentrated, virus-inactivated preparation of neutralizing antibodies (NAbs) …
[HTML][HTML] Viral clearance strategy using a three-tier orthogonal technology platform
S Ray, K Tarrach - BioPharm International, 2008 - biopharminternational.com
Removing viral contaminants from animal cell-culture derived biologicals is a major challenge
of downstream purification because it involves laborious and time-consuming techniques …
of downstream purification because it involves laborious and time-consuming techniques …
Biochemical and Functional Characterization of Plasma Derived Human Celestrase 1
S Dolia, S Verma, S Ray - Plasmatology, 2024 - journals.sagepub.com
… of Plasma Derived Human Celestrase 1 - Sheetal Dolia, Sachin Verma, Suma Ray, 2024 …
Suma Ray, PhD 1 … Suma Ray has provided technical input and guidance for this project. …
Suma Ray, PhD 1 … Suma Ray has provided technical input and guidance for this project. …
Quality attributes of plasma derived human fibrinogen (fibrogen-I®)
S Dolia, S Verma, A Pawar, S Ray - Plasmatology, 2021 - journals.sagepub.com
… Suma Ray … Suma Ray, Plasma Operations, Intas Pharmaceuticals Ltd (Plasma Fractionation
unit), … Dr Suma Ray provided continuous technical inputs and mentorship for this project. …
unit), … Dr Suma Ray provided continuous technical inputs and mentorship for this project. …
[PDF][PDF] RINT WITH PERMISSION O REPRINT WITH
…, S Dolia, A Pawar, S Ray - BioProcess …, 2021 - eu-assets.contentstack.com
April 2021 19 (4) BioProcess International 31 than classical CP therapy. The resulting drug
product would provide more consistent antibody levels in each lot, and units would be easy …
product would provide more consistent antibody levels in each lot, and units would be easy …
[HTML][HTML] Characterization of high-purity, double virus inactivated and stable plasma-derived anti-haemophilic clotting factor-VIII/vWF complex
…, A Pawar, S Bardhan, V Patel, S Verma, S Ray - Annals of …, 2019 - aob.amegroups.org
Background: The success in the management of haemophilia in the last two decades has
been predominantly due to the availability of sufficient quantities of safe anti-haemophilic …
been predominantly due to the availability of sufficient quantities of safe anti-haemophilic …